{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:14:29Z","timestamp":1723508069828},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,12]]},"DOI":"10.7759\/cureus.66676","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T12:00:34Z","timestamp":1723464034000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Neuroendocrine Carcinoma of the Ileum With Markedly Elevated Carcinoembryonic Antigen (CEA) Levels: A Case Report"],"prefix":"10.7759","author":[{"given":"Aya","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Nakamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Carcinoembryonic antigen (CEA) family","author":"Schenkel-Brunner H","year":"2000","unstructured":"Schenkel-Brunner H. Carcinoembryonic antigen (CEA) family. Human Blood Groups. Springer, Vienna; 2000."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel M","year":"2020","unstructured":"Pavel M, \u00d6berg K, Falconi M, Krenning EP, Sundin A, Perren A, Berruti A. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020, 31:844-60. 10.1016\/j.annonc.2020.03.304","journal-title":"Ann Oncol"},{"key":"ref3","article-title":"Classification of neuroendocrine neoplasms of the digestive system","author":"Klimstra D","year":"2019","unstructured":"Klimstra D, Kl\u00f6ppel G, La Rosa S, Rindi G. Classification of neuroendocrine neoplasms of the digestive system. Lyon (ed): IARC, 2019."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s40792-020-00945-3","article-title":"Rapidly progressed neuroendocrine carcinoma in the extrahepatic bile duct: a case report and review of the literature","volume":"6","author":"Kamiya M","year":"2020","unstructured":"Kamiya M, Yamamoto N, Kamioka Y, et al.. Rapidly progressed neuroendocrine carcinoma in the extrahepatic bile duct: a case report and review of the literature. Surg Case Rep. 2020, 6:191. 10.1186\/s40792-020-00945-3","journal-title":"Surg Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer EA","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al.. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45:228-47. 10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2023.01.004","article-title":"Reprint of: the diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres (ALT) to the evaluation of pancreatic neuroendocrine tumors (PanNETs)","volume":"132","author":"Heaphy CM","year":"2023","unstructured":"Heaphy CM, Singhi AD. Reprint of: the diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres (ALT) to the evaluation of pancreatic neuroendocrine tumors (PanNETs). Hum Pathol. 2023, 132:1-11. 10.1016\/j.humpath.2023.01.004","journal-title":"Hum Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-020-09660-z","article-title":"Genomics of high-grade neuroendocrine neoplasms: well-differentiated neuroendocrine tumor with high-grade features (G3 NET) and neuroendocrine carcinomas (NEC) of Various anatomic sites","volume":"32","author":"Uccella S","year":"2021","unstructured":"Uccella S, La Rosa S, Metovic J, et al.. Genomics of high-grade neuroendocrine neoplasms: well-differentiated neuroendocrine tumor with high-grade features (G3 NET) and neuroendocrine carcinomas (NEC) of Various anatomic sites. Endocr Pathol. 2021, 32:192-210. 10.1007\/s12022-020-09660-z","journal-title":"Endocr Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnad006","article-title":"Advances in the treatment of gastroenteropancreatic neuroendocrine carcinomas: are we moving forward?","volume":"44","author":"Garcia-Carbonero R","year":"2023","unstructured":"Garcia-Carbonero R, Anton-Pascual B, Modrego A, et al.. Advances in the treatment of gastroenteropancreatic neuroendocrine carcinomas: are we moving forward?. Endocr Rev. 2023, 44:724-36. 10.1210\/endrev\/bnad006","journal-title":"Endocr Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2023.01.009","article-title":"Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms","volume":"23","author":"Gao C","year":"2023","unstructured":"Gao C, Fan Z, Yang J, Shi M, Li Y, Zhan H. Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms. Pancreatology. 2023, 23:204-12. 10.1016\/j.pan.2023.01.009","journal-title":"Pancreatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1457496919874484","article-title":"Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops","volume":"110","author":"Eriksson J","year":"2021","unstructured":"Eriksson J, Norl\u00e9n O, \u00d6gren M, Garmo H, Ihre-Lundgren C, Hellman P. Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops. Scand J Surg. 2021, 110:44-50. 10.1177\/1457496919874484","journal-title":"Scand J Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF02934114","article-title":"Gastric neuroendocrine carcinoma associated with chronic atrophic gastritis type A","volume":"32","author":"Kaizaki Y","year":"1997","unstructured":"Kaizaki Y, Fujii T, Kawai T, Saito K, Kurihara K, Fukayama M. Gastric neuroendocrine carcinoma associated with chronic atrophic gastritis type A. J Gastroenterol. 1997, 32:643-9. 10.1007\/BF02934114","journal-title":"J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF01600306","article-title":"Metastasizing neuroendocrine carcinoma of the larynx with calcitonin and somatostatin secretion and CEA production, resembling medullary thyroid carcinoma","volume":"416","author":"Smets G","year":"1990","unstructured":"Smets G, Warson F, Dehou MF, et al.. Metastasizing neuroendocrine carcinoma of the larynx with calcitonin and somatostatin secretion and CEA production, resembling medullary thyroid carcinoma. Virchows Arch A Pathol Anat Histopathol. 1990, 416:539-43. 10.1007\/BF01600306","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57060609","article-title":"A review of the significance in measuring preoperative and postoperative carcinoembryonic antigen (CEA) values in patients with medullary thyroid carcinoma (MTC)","volume":"57","author":"Passos I","year":"2021","unstructured":"Passos I, Stefanidou E, Meditskou-Eythymiadou S, et al.. A review of the significance in measuring preoperative and postoperative carcinoembryonic antigen (CEA) values in patients with medullary thyroid carcinoma (MTC). Medicina (Kaunas). 2021, 57:10.3390\/medicina57060609","journal-title":"Medicina (Kaunas)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3181ebb4f0","article-title":"The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer","volume":"39","author":"Chen H","year":"2010","unstructured":"Chen H, Sippel RS, O'Dorisio MS, Vinik AI, Lloyd RV, Pacak K. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas. 2010, 39:775-83. 10.1097\/MPA.0b013e3181ebb4f0","journal-title":"Pancreas"},{"key":"ref15","article-title":"The carcinoembryonic antigen as a potential prognostic marker for neuroendocrine carcinoma of the breast","volume":"32","author":"Su CH","year":"2012","unstructured":"Su CH, Chang H, Chen CJ, et al.. The carcinoembryonic antigen as a potential prognostic marker for neuroendocrine carcinoma of the breast. Anticancer research. 2012, 32:183-188.","journal-title":"Anticancer research"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-008778","article-title":"Malignant neuroendocrine tumour of the gallbladder with elevated carcinoembryonic antigen: case report and literature review","volume":"2013","author":"Furrukh M","year":"2013","unstructured":"Furrukh M, Qureshi A, Saparamadu A, Kumar S. Malignant neuroendocrine tumour of the gallbladder with elevated carcinoembryonic antigen: case report and literature review. BMJ Case Rep. 2013, 2013:10.1136\/bcr-2013-008778","journal-title":"BMJ Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/ijmpo.ijmpo_72_17","article-title":"Extensive metastases in prostatic carcinoma with normal prostate-specific antigen and raised carcinoembryonic antigen - small cell carcinoma of prostate: a rare entity","volume":"39","author":"Khaladkar SM","year":"2021","unstructured":"Khaladkar SM, Jain KM, Ghosh A, Kuber R. Extensive metastases in prostatic carcinoma with normal prostate-specific antigen and raised carcinoembryonic antigen - small cell carcinoma of prostate: a rare entity. Ind Jr Med Pae Onc. 2021, 39:539-542. 10.4103\/ijmpo.ijmpo_72_17","journal-title":"Ind Jr Med Pae Onc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5084-0","article-title":"Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report","volume":"18","author":"Yamaura M","year":"2018","unstructured":"Yamaura M, Yamada T, Watanabe R, et al.. Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report. BMC Cancer. 2018, 18:1142. 10.1186\/s12885-018-5084-0","journal-title":"BMC Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/01.MPA.0000357035.23040.b3","article-title":"Islet cell carcionoma with high levels of carcinoembryonic antigen and glucagon","volume":"38","author":"Nishida T","year":"2009","unstructured":"Nishida T, Yamamoto K, Tsutsui S, et al.. Islet cell carcionoma with high levels of carcinoembryonic antigen and glucagon. Pancreas. 2009, 38:487. 10.1097\/01.MPA.0000357035.23040.b3","journal-title":"Pancreas"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173501","article-title":"Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases","volume":"12","author":"Egashira A","year":"2017","unstructured":"Egashira A, Morita M, Kumagai R, et al.. Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases. PLoS One. 2017, 12:e0173501. 10.1371\/journal.pone.0173501","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/281817-primary-neuroendocrine-carcinoma-of-the-ileum-with-markedly-elevated-carcinoembryonic-antigen-cea-levels-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T12:00:37Z","timestamp":1723464037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/281817-primary-neuroendocrine-carcinoma-of-the-ileum-with-markedly-elevated-carcinoembryonic-antigen-cea-levels-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.66676","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,12]]}}}